450 related articles for article (PubMed ID: 26853911)
1. The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.
Pitek AS; Wen AM; Shukla S; Steinmetz NF
Small; 2016 Apr; 12(13):1758-69. PubMed ID: 26853911
[TBL] [Abstract][Full Text] [Related]
2. Interactions Between Plant Viral Nanoparticles (VNPs) and Blood Plasma Proteins, and Their Impact on the VNP In Vivo Fates.
Pitek AS; Veliz FA; Jameson SA; Steinmetz NF
Methods Mol Biol; 2018; 1776():591-608. PubMed ID: 29869268
[TBL] [Abstract][Full Text] [Related]
3. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.
Pitek AS; Jameson SA; Veliz FA; Shukla S; Steinmetz NF
Biomaterials; 2016 May; 89():89-97. PubMed ID: 26950168
[TBL] [Abstract][Full Text] [Related]
5. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
6. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
Su G; Jiang H; Xu B; Yu Y; Chen X
Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
[TBL] [Abstract][Full Text] [Related]
7. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system.
Assali A; Razzazan S; Akhavan O; Mottaghitalab F; Adeli M; Atyabi F
Colloids Surf B Biointerfaces; 2019 Jan; 173():891-898. PubMed ID: 30551306
[TBL] [Abstract][Full Text] [Related]
8. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
10. On the formation of protein corona on colloidal nanoparticles stabilized by depletant polymers.
Petry R; Saboia VM; Franqui LS; Holanda CA; Garcia TRR; de Farias MA; de Souza Filho AG; Ferreira OP; Martinez DST; Paula AJ
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110080. PubMed ID: 31546390
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
13. Protein corona composition of poly(ethylene glycol)- and poly(phosphoester)-coated nanoparticles correlates strongly with the amino acid composition of the protein surface.
Settanni G; Zhou J; Suo T; Schöttler S; Landfester K; Schmid F; Mailänder V
Nanoscale; 2017 Feb; 9(6):2138-2144. PubMed ID: 28124700
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
15. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
16. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
17. Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles.
Chariou PL; Wang L; Desai C; Park J; Robbins LK; von Recum HA; Ghiladi RA; Steinmetz NF
Macromol Biosci; 2019 May; 19(5):e1800407. PubMed ID: 30721575
[TBL] [Abstract][Full Text] [Related]
18. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
19. Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles.
Weiss ACG; Kelly HG; Faria M; Besford QA; Wheatley AK; Ang CS; Crampin EJ; Caruso F; Kent SJ
ACS Nano; 2019 May; 13(5):4980-4991. PubMed ID: 30998312
[TBL] [Abstract][Full Text] [Related]
20. Protein corona formation on lipidic nanocapsules: Influence of the interfacial PEG repartition.
Lebreton V; Legeay S; Vasylaki A; Lagarce F; Saulnier P
Eur J Pharm Sci; 2023 Oct; 189():106537. PubMed ID: 37490974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
